Pilonidal disease
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
asymptomatic
hair removal and perineal hygiene
Surgery is not indicated in asymptomatic patients. Although data is limited in asymptomatic disease, conservative treatment with hair removal, improved perineal hygiene, weight loss, and avoiding prolonged sitting can be considered as it is low risk.[14]Johnson EK, Vogel JD, Cowan ML, et al. The American Society of Colon and Rectal Surgeons' clinical practice guidelines for the management of pilonidal disease. Dis Colon Rectum. 2019 Feb;62(2):146-57. https://journals.lww.com/dcrjournal/fulltext/2019/02000/the_american_society_of_colon_and_rectal_surgeons_.5.aspx
symptomatic with abscess
incision and drainage and/or unroofing and curettage
All acute pilonidal abscesses should undergo prompt incision and drainage. Depending on patient presentation and facility resources, it is ideal to debride all inflammatory debris and visible hair within an abscess cavity.[14]Johnson EK, Vogel JD, Cowan ML, et al. The American Society of Colon and Rectal Surgeons' clinical practice guidelines for the management of pilonidal disease. Dis Colon Rectum. 2019 Feb;62(2):146-57. https://journals.lww.com/dcrjournal/fulltext/2019/02000/the_american_society_of_colon_and_rectal_surgeons_.5.aspx In one randomised controlled trial comparing unroofing and curettage of the abscess to standard drainage, 96% of patients in the curettage group had complete wound healing within 10 weeks, compared with 79% of patients in the drainage group. Recurrence was also significantly less in patients treated with the curettage instead of simple drainage (11% vs. 42%).[15]Vahedian J, Nabavizadeh F, Nakhaee N, et al. Comparison between drainage and curettage in the treatment of acute pilonidal abscess. Saudi Med J. 2005 Apr;26(4):553-5. http://www.ncbi.nlm.nih.gov/pubmed/15900358?tool=bestpractice.com
antibiotic therapy
Additional treatment recommended for SOME patients in selected patient group
There is no conclusive evidence to support routine use of peri-procedural antibiotics, although expert opinion has suggested a role in patients with significant cellulitis after surgical drainage or those with underlying immunosuppression, high risk of endocarditis, methicillin-resistant Staphylococcus aureus (MRSA), or concurrent systemic illness.[16]Mavros MN, Mitsikostas PK, Alexiou VG, et al. Antimicrobials as an adjunct to pilonidal disease surgery: a systematic review of the literature. Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):851-8. http://www.ncbi.nlm.nih.gov/pubmed/23380885?tool=bestpractice.com [17]Segre D, Pozzo M, Perinotti R, et al. The treatment of pilonidal disease: guidelines of the Italian Society of Colorectal Surgery (SICCR). Tech Coloproctol. 2015 Oct;19(10):607-13. http://www.ncbi.nlm.nih.gov/pubmed/26377583?tool=bestpractice.com If antibiotics are indicated, amoxicillin/clavulanate is sufficient coverage. If amoxicillin/clavulanate is contraindicated, a fluoroquinolone (e.g., ciprofloxacin) combined with metronidazole is adequate.
Systemic fluoroquinolone antibiotics, such as ciprofloxacin, may cause serious, disabling, and potentially long-lasting or irreversible adverse events. This includes, but is not limited to: tendinopathy/tendon rupture; peripheral neuropathy; arthropathy/arthralgia; aortic aneurysm and dissection; heart valve regurgitation; dysglycaemia; and central nervous system effects including seizures, depression, psychosis, and suicidal thoughts and behaviour.[18]Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804. https://www.mdpi.com/1999-4923/15/3/804 http://www.ncbi.nlm.nih.gov/pubmed/36986665?tool=bestpractice.com Prescribing restrictions apply to the use of fluoroquinolones, and these restrictions may vary between countries. In general, fluoroquinolones should be restricted for use in serious, life-threatening bacterial infections only. Some regulatory agencies may also recommend that they must only be used in situations where other antibiotics, that are commonly recommended for the infection, are inappropriate (e.g., resistance, contraindications, treatment failure, unavailability). Consult your local guidelines and drug formulary for more information on suitability, contraindications, and precautions.
Primary options
amoxicillin/clavulanate: 500 mg orally three times daily
More amoxicillin/clavulanateDose refers to amoxicillin component.
Secondary options
ciprofloxacin: 750 mg orally twice daily
and
metronidazole: 500 mg orally three times daily
hair removal and perineal hygiene
Additional treatment recommended for SOME patients in selected patient group
Recurrence rates following simple drainage have been reported as high as 55%.[17]Segre D, Pozzo M, Perinotti R, et al. The treatment of pilonidal disease: guidelines of the Italian Society of Colorectal Surgery (SICCR). Tech Coloproctol. 2015 Oct;19(10):607-13. http://www.ncbi.nlm.nih.gov/pubmed/26377583?tool=bestpractice.com Following drainage, conservative strategies including perineal hygiene and cleft hair removal by either shaving, laser, or depilatory cream should be utilised to minimise recurrence rates. Of note, razor/cream depilation in the immediate postoperative rate has been associated with a higher recurrence rate. One systematic review on postoperative hair removal showed that postoperative laser epilation was associated with a lower recurrence rate (9%) than razor/cream depilation (23%) and no hair removal after surgery (20%).[19]Pronk AA, Eppink L, Smakman N, et al. The effect of hair removal after surgery for sacrococcygeal pilonidal sinus disease: a systematic review of the literature. Tech Coloproctol. 2018 Jan;22(1):7-14. http://www.ncbi.nlm.nih.gov/pubmed/29185064?tool=bestpractice.com
symptomatic chronic or recurrent disease
surgical treatment
Surgical therapy is the mainstay of treatment for pilonidal sinus and aims to remove all the diseased tissue. Many surgical techniques have been described, but the optimal procedure is still controversial because of high recurrence rates and associated morbidity. Surgical options include excision with delayed wound closure, excision with midline primary closure, excision with primary off-midline closure (flap-based techniques), sinusectomy (aka trephination/Gips procedure), and endoscopic pilonidal sinus treatment.[4]Gil LA, Deans KJ, Minneci PC. Management of pilonidal disease: a review. JAMA Surg. 2023 Aug 1;158(8):875-83. http://www.ncbi.nlm.nih.gov/pubmed/37256592?tool=bestpractice.com [14]Johnson EK, Vogel JD, Cowan ML, et al. The American Society of Colon and Rectal Surgeons' clinical practice guidelines for the management of pilonidal disease. Dis Colon Rectum. 2019 Feb;62(2):146-57. https://journals.lww.com/dcrjournal/fulltext/2019/02000/the_american_society_of_colon_and_rectal_surgeons_.5.aspx
The available literature suggests that surgical treatment should be tailored specifically to the patient taking into consideration recurrence rates, wound complication rates, time to healing, and time to return to activities.
hair removal and perineal hygiene
Additional treatment recommended for SOME patients in selected patient group
One systematic review on postoperative hair removal showed that postoperative laser epilation was associated with a lower recurrence rate (9%) than razor/cream depilation (23%) and no hair removal after surgery (20%).[19]Pronk AA, Eppink L, Smakman N, et al. The effect of hair removal after surgery for sacrococcygeal pilonidal sinus disease: a systematic review of the literature. Tech Coloproctol. 2018 Jan;22(1):7-14. http://www.ncbi.nlm.nih.gov/pubmed/29185064?tool=bestpractice.com
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer